23 results
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
26 Sep 24
Regulation FD Disclosure
7:00am
– groundbreaking to complete validation in 2 years Design Build Operations Nov 8, 2021 Groundbreaking Nov 25, 2022 First clean room operational May 2023 Capacity
8-K
AUTL
Autolus Therapeutics plc
13 Sep 24
Entry into a Material Definitive Agreement
9:08am
the creation and fit out of additional clean rooms for product manufacture, which the Company has agreed to complete on a mutually agreed schedule. Once
8-K
EX-99.1
AUTL
Autolus Therapeutics plc
5 Jun 24
Registered Number 11185179 (England & Wales) Annual Report and financial statements for the year ended 31 December 2023 for Autolus Therapeutics plc
4:35pm
. The Nucleus provides multiple clean rooms, QC labs, warehouse and administrative space and is being fitted out in a phased manner as demand requires. At full
8-K
EX-99.2
AUTL
Autolus Therapeutics plc
17 May 24
Results of Operations and Financial Condition
8:27am
validation in 2 years Design Build Operations Nov 8, 2021 Groundbreaking Nov 25, 2022 First clean room operational May 2023 Capacity challenge 2021 2022
10-K
r9rix58feaa5l51jl5z
21 Mar 24
Annual report
4:55pm
8-K
EX-99.1
153 5hxer2yzgs
13 Feb 24
Regulation FD Disclosure
4:06pm
8-K
EX-1.1
gxtuv wsnkw5phe5
8 Feb 24
Autolus Announces Pricing of Underwritten Offering
4:17pm
8-K
EX-10.1
fvfv2v
8 Feb 24
BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs
6:06am
10-Q
EX-10.1
kk3iaud6cuoh1ah2
9 Nov 23
Quarterly report
4:18pm
6-K
EX-99.2
pq9ml5f
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.1
ordfnru8odlzrrw9li
3 Aug 23
Index to Condensed Consolidated Financial Statements
4:32pm
6-K
EX-99.1
fggixkq
4 May 23
Index to Condensed Consolidated Financial Statements
4:04pm
6-K
EX-1.1
nwrct0oi1dm q6u
9 Dec 22
Autolus Announces Pricing of Public Offering
5:43pm
6-K/A
EX-99.2
lwj8s3n5
21 Nov 22
Current report (foreign) (amended)
4:03pm
6-K
EX-99.3
btrzl5dpxrj6rpzmmbva
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.2
g9uzcjbxyx uvcyla
3 Nov 22
Index to Condensed Consolidated Financial Statements
10:31am
6-K
EX-99.1
p2x1dcilb125oyn2y4
8 Nov 21
Securities Purchase Agreement
5:28pm
6-K
EX-1.1
zf8y4rv5
11 Feb 21
Autolus Announces Proposed Public Offering in the United States
5:18pm
6-K
EX-1.1
2x24g
18 Sep 20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO
7:12am